Reply to: Marketing pitches of ‘magic mushrooms’ and ‘psychedelics’ mask that psychotomimetics use exposes those vulnerable to serious adverse effects

Emma Morton; Kimberly Sakai; Amir Ashtari; Mollie Pleet; Erin E. Michalak; Josh Woolley

doi:10.1177/02698811231169641a

Reply to: Marketing pitches of ‘magic mushrooms’ and ‘psychedelics’ mask that psychotomimetics use exposes those vulnerable to serious adverse effects

Emma Morton, Kimberly Sakai, Amir Ashtari, Mollie Pleet, Erin E. Michalak, Josh Woolley

Research output: Contribution to journal › Letter › Other › peer-review

Original language	English
Pages (from-to)	750-751
Number of pages	2
Journal	Journal of Psychopharmacology
Volume	37
Issue number	7
DOIs	https://doi.org/10.1177/02698811231169641a
Publication status	Published - Jul 2023
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1177/02698811231169641a

Cite this

@article{b2749bab2a69427a9913f7f99a5213ba,

title = "Reply to: Marketing pitches of {\textquoteleft}magic mushrooms{\textquoteright} and {\textquoteleft}psychedelics{\textquoteright} mask that psychotomimetics use exposes those vulnerable to serious adverse effects",

author = "Emma Morton and Kimberly Sakai and Amir Ashtari and Mollie Pleet and Michalak, {Erin E.} and Josh Woolley",

year = "2023",

month = jul,

doi = "10.1177/02698811231169641a",

language = "English",

volume = "37",

pages = "750--751",

journal = "Journal of Psychopharmacology",

issn = "0269-8811",

publisher = "SAGE Publications Ltd",

number = "7",

}

TY - JOUR

T1 - Reply to

T2 - Marketing pitches of ‘magic mushrooms’ and ‘psychedelics’ mask that psychotomimetics use exposes those vulnerable to serious adverse effects

AU - Morton, Emma

AU - Sakai, Kimberly

AU - Ashtari, Amir

AU - Pleet, Mollie

AU - Michalak, Erin E.

AU - Woolley, Josh

PY - 2023/7

Y1 - 2023/7

UR - http://www.scopus.com/inward/record.url?scp=85164541327&partnerID=8YFLogxK

U2 - 10.1177/02698811231169641a

DO - 10.1177/02698811231169641a

M3 - Letter

C2 - 37132540

AN - SCOPUS:85164541327

SN - 0269-8811

VL - 37

SP - 750

EP - 751

JO - Journal of Psychopharmacology

JF - Journal of Psychopharmacology

IS - 7

ER -

Reply to: Marketing pitches of ‘magic mushrooms’ and ‘psychedelics’ mask that psychotomimetics use exposes those vulnerable to serious adverse effects

UN SDGs

Access to Document

Other files and links

Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption

Cite this